The Irrelevance of In Vitro Dissolution in Setting Product Specifications for Drugs Like Dextromethorphan That are Subject to Lysosomal Trapping-Reference-Cited by-同舟云学术

The Irrelevance of In Vitro Dissolution in Setting Product Specifications for Drugs Like Dextromethorphan That are Subject to Lysosomal Trapping

Published:2019-01 Issue:1 Volume:108 Page:268-278
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Bolger Michael B.,Macwan Joyce S.,Sarfraz Muhammad,Almukainzi May,Löbenberg Raimar

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference44 articles.

1. Kinetics of distribution of substances administered to the body, I: the extravascular modes of administration;Teorell;Arch Int Pharmacodyn Ther,1937

2. Kinetics of distribution of substances administered to the body, II: the intravascular modes of administration;Teorell;Arch Int Pharmacodyn Ther,1937

3. Anatomy of body water and electrolytes;Edelman;Am J Med,1959

4. Thiopental pharmacokinetics;Bischoff;J Pharm Sci,1968

5. Physiologically based pharmacokinetic study on a cyclosporin derivative, SDZ IMM 125;Kawai;J Pharmacokinet Biopharm,1994

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parameterization of Physiologically Based Biopharmaceutics Models: Workshop Summary Report;Molecular Pharmaceutics;2024-07-01

2. Evaluating gender effect in the generic bioequivalence studies by physiologically based pharmacokinetic modeling – A case study of dextromethorphan modified release tablets;Biopharmaceutics & Drug Disposition;2024-05-22

3. In Silico Prediction of Oral Drug Absorption;Oral Bioavailability and Drug Delivery;2023-10-10

4. Development of Extended-Release Formulations Containing Cyclobenzaprine Based on Physiologically Based Biopharmaceutics Modeling and Bioequivalence Safe Space;Journal of Pharmaceutical Sciences;2023-07

5. Development of Biopredictive Dissolution Method for Extended-Release Desvenlafaxine Tablets;Pharmaceutics;2023-05-19